Polygonatum cyrtonema Hua Polysaccharide Promotes GLP‑1 Secretion from Enteroendocrine L‑Cells through Sweet Taste Receptor-Mediated cAMP Signaling

• Published in: Journal of agricultural and food chemistry Vol. 68; no. 25; pp. 6864 - 6872
• Main Authors: Xie, Song-Zi, Yang, Guang, Jiang, Xian-Min, Qin, Dan-Yang, Li, Qiang-Ming, Zha, Xue-Qiang, Pan, Li-Hua, Jin, Chuan-Shan, Luo, Jian-Ping
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 24.06.2020
• Subjects: Animals; Bioactive Constituents, Metabolites, and Functions; Cyclic AMP - metabolism; Enteroendocrine Cells - drug effects; Enteroendocrine Cells - metabolism; Glucagon-Like Peptide 1 - metabolism; Male; Mice; Mice, Inbred C57BL; Plant Extracts - pharmacology; Polygonatum - chemistry; Polysaccharides - pharmacology; Rats; Rats, Sprague-Dawley; Receptors, G-Protein-Coupled - genetics; Receptors, G-Protein-Coupled - metabolism; Signal Transduction - drug effects; polysaccharide; sweet taste receptor; Polygonatum cyrtonema; glucagon-like peptide-1; cAMP signaling pathway
• ISSN: 0021-8561; 1520-5118
• DOI: 10.1021/acs.jafc.0c02058

Glucagon-like peptide-1 (GLP-1) secreted from enteroendocrine L-cells is a pleiotropic hormone with beneficial potential related to islet function, diet control, glucose homeostasis, inflammation relief, and cardiovascular protection. The present study aimed at investigating the effect of Polygonatum cyrtonema polysaccharide (PCP) after structural identification on GLP-1 secretion and the possible mechanism involved in the PCP-stimulated secretion of GLP-1. It was found that GLP-1 secretion was effectively promoted (p < 0.01) by PCP both in rats with oral administration for 5 weeks (13.9 ± 0.3–35.8 ± 0.3 pmol/L) and ileal administration within 2 h (13.6 ± 0.4–34.1 ± 1.1 pmol/L) and in enteroendocrine NCI-H716 cells with direct stimulation within 24 h (2.05 ± 0.3–20.7 ± 0.2 pmol/L). The sweet taste receptor T1R2/T1R3 was identified to be essential for NCI-H716 cells to directly recognize PCP. The intervention experiments showed that PCP-stimulated GLP-1 secretion was significantly depressed (p < 0.01) not only by antibodies, siRNA, and the inhibitor of T1R2/T1R3 but also by an adenylate cyclase inhibitor. These results suggest that PCP stimulates GLP-1 secretion from enteroendocrine cells possibly through activation of the T1R2/T1R3-mediated cAMP signaling pathway.